Coya Therapeutics Reports Additional Blood Biomarker and Brain Imaging Data Showing Decrease in Neuroinflammation Following Treatment with COYA 301 in Alzheimer’s Disease (AD) - Allele Capital

https://ir.coyatherapeutics.com/news/news-details/2023/Coya-Therapeutics-Reports-Additional-Blood-Biomarker-and-Brain-Imaging-Data-Showing-Decrease-in-Neuroinflammation-Following-Treatment-with-COYA-301-in-Alzheimers-Disease-AD/default.aspx